Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions

Completed · Phase 1

Conditions studied: Healthy

In brief

To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 00345439 formulation under fed conditions in healthy volunteers.

Key facts

Study ID

NCT02089295

Run by

Pain Therapeutics

People needed

18

Starts

2014-04-01

Expected to finish

2014-06-01

Last updated by the study team

2016-04-04

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and/or female subjects between 18 and 55 years of age

You may not qualify if…

• Evidence or history of clinically significant disease.
• Positive urine drug test

Where it is running

• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.